Last reviewed · How we verify
NCT07071428: ATPTD
Acupuncture Treatment in Pediatric Patients With Tic Disorders: A Prospective, Single-Center, Randomized Controlled Trial
NA trial testing Regular acupuncture in Tic Disorders in 76 participants. Completed in 1 December 2022.
11 July 2022
Quick facts
| Lead sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 76 |
| Start date | 1 August 2021 |
| Primary completion | 11 July 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Regular acupuncture
- the Nourishing the vital energyand Regulating the spirit needle technique
Conditions studied
- Tic Disorders — all drugs for Tic Disorders →
Sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Who can join
Adults 5 to 18, any sex, with Tic Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to observe the efficacy of Nourishing the vital energy and Regulating the spirit needle technique in the treatment of chronic tic disorder through the Yale Global Tic Severity Scale (YGTSS) and the Chinese Medicine Symptom Rating Scale in order to provide a new, safe and feasible treatment option and idea for the treatment of chronic Tic Disorder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07071428
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tic Disorders
Currently open trials in the same condition.
- NCT07351955 — Clinical Study on a Novel Strategy of Individualized Non-Invasive Neuromodulation for the Treatment of Tic Disorders in · NA · recruiting
- NCT06679790 — Trajectories of Change in Tourette Syndrome · NA · recruiting
- NCT06050369 — Objective Characterizatoion of Repetitive Behaviors · NA · recruiting
- NCT05370391 — Comprehensive Behavioral Intervention for Tics · NA · recruiting
- NCT05317390 — Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia · NA · recruiting
Other The Third Affiliated hospital of Zhejiang Chinese Medical University trials
Trials by the same sponsor.
- NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures · NA · not yet recruiting
- NCT07496580 — Efficacy Evaluation of Electroacupuncture in the Treatment of Functional Dyspepsia · NA · not yet recruiting
- NCT07325045 — Biomechanical Study of Lever Positioning Manipulation on Scoliosis · NA · not yet recruiting
- NCT07250308 — Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms · recruiting
- NCT07308951 — Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07071428 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Affiliated hospital of Zhejiang Chinese Medical University
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07071428.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing